Skip to main content

Peer Review reports

From: Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

Original Submission
6 Sep 2022 Submitted Original manuscript
15 Sep 2022 Author responded Author comments - Peter Taylor
Resubmission - Version 2
15 Sep 2022 Submitted Manuscript version 2
28 Sep 2022 Reviewed Reviewer Report
30 Oct 2022 Reviewed Reviewer Report
2 Dec 2022 Author responded Author comments - Peter Taylor
Resubmission - Version 3
2 Dec 2022 Submitted Manuscript version 3
9 Dec 2022 Reviewed Reviewer Report
23 Dec 2022 Reviewed Reviewer Report
19 Jan 2023 Author responded Author comments - Peter Taylor
Resubmission - Version 4
19 Jan 2023 Submitted Manuscript version 4
Publishing
20 Jan 2023 Editorially accepted
14 Feb 2023 Article published 10.1186/s12916-023-02746-5

You can find further information about peer review here.

Back to article page